Charles Schwab Investment Management Inc Biomea Fusion, Inc. Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 208,391 shares of BMEA stock, worth $835,647. This represents 0.0% of its overall portfolio holdings.
Number of Shares
208,391
Previous 200,840
3.76%
Holding current value
$835,647
Previous $903,000
133.0%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding BMEA
# of Institutions
104Shares Held
17.8MCall Options Held
1.68MPut Options Held
410K-
Cormorant Asset Management, LP Boston, MA3.57MShares$14.3 Million2.53% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$9.4 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY2.11MShares$8.46 Million0.23% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.4MShares$5.61 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.38MShares$5.53 Million0.01% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $117M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...